| Literature DB >> 22728504 |
Masakazu Teragaki1, Hitomi Kawano, Ryojiro Makino, Keisuke Inoue, Yoshinori Sai, Mitsuharu Hosono, Shigefumi Suehiro, Mikio Okamura.
Abstract
Warfarin is widely used in clinical practice all over the world. We report a man in whom prominent eosinophilia appeared after the initiation of warfarin administration following aortic valve replacement. Laboratory data following the administration and discontinuation of warfarin suggested that this drug was responsible for the eosinophilia. It is important to recognize the possibility of warfarin-induced hypereosinophilia as a latent adverse effect even when there are no clinical signs or symptoms.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22728504 DOI: 10.2169/internalmedicine.51.7138
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271